Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127081361 | 12708136 | 1 | I | 20160729 | 20160825 | 20160901 | 20160901 | PER | US-PFIZER INC-2016406350 | PFIZER | 56.00 | YR | F | Y | 58.00000 | KG | 20160901 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127081361 | 12708136 | 1 | PS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 20 MG, DAILY (40 MG 1/2 TABLET) | Y | 20702 | 20 | MG | FILM-COATED TABLET | ||||||
| 127081361 | 12708136 | 2 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 40 MG, DAILY (WHOLE DOSE THE SECOND HALF THAT WEEK) | Y | 20702 | 40 | MG | FILM-COATED TABLET | ||||||
| 127081361 | 12708136 | 3 | C | BAYER ASPIRIN | ASPIRIN | 1 | Oral | 162 MG, DAILY (81 MG 2 TABLETS) | 0 | 162 | MG | TABLET | |||||||
| 127081361 | 12708136 | 4 | C | ARIMIDEX | ANASTROZOLE | 1 | Oral | 1 MG, 1X/DAY | 0 | 1 | MG | TABLET | QD | ||||||
| 127081361 | 12708136 | 5 | C | VITAMIN D /00107901/ | ERGOCALCIFEROL | 1 | Oral | 10000 IU, DAILY (5000 IU TWO TABLETS) | 0 | 10000 | IU | TABLET | |||||||
| 127081361 | 12708136 | 6 | C | VITAMIN D /00107901/ | ERGOCALCIFEROL | 1 | 0 | TABLET | |||||||||||
| 127081361 | 12708136 | 7 | C | OMEGA 3 FISH OIL /01334101/ | FISH OIL | 1 | Oral | 2000 MG, DAILY (1000MG, TWO LIQUIGELS) | 0 | 2000 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127081361 | 12708136 | 1 | Blood cholesterol increased |
| 127081361 | 12708136 | 3 | Blood disorder |
| 127081361 | 12708136 | 4 | Cancer hormonal therapy |
| 127081361 | 12708136 | 5 | Vitamin D deficiency |
| 127081361 | 12708136 | 6 | Supplementation therapy |
| 127081361 | 12708136 | 7 | Blood triglycerides |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127081361 | 12708136 | Confusional state | |
| 127081361 | 12708136 | Diarrhoea | |
| 127081361 | 12708136 | Dizziness | |
| 127081361 | 12708136 | Hyperhidrosis | |
| 127081361 | 12708136 | Nausea | |
| 127081361 | 12708136 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127081361 | 12708136 | 1 | 20160729 | 20160823 | 0 | |
| 127081361 | 12708136 | 4 | 20150218 | 0 | ||
| 127081361 | 12708136 | 5 | 2014 | 0 | ||
| 127081361 | 12708136 | 7 | 2015 | 0 |